Joel B. Epstein

Antimicrobial therapy to prevent or treat oral mucositis.

S. Sonis, J. Epstein, J. Donnelly, 2003, The Lancet. Infectious diseases.

Updated clinical practice guidelines for the prevention and treatment of mucositis

J. Raber-Durlacher, C. Migliorati, Ronald D. Hutchins, 2007, Cancer.

Clinical practice guidelines for the prevention and treatment of cancer therapy–induced oral and gastrointestinal mucositis

D. McGuire, L. Elting, E. Rubenstein, 2004, Cancer.

Clinical Practice Guidelines for the Prevention and Treatment of Mucositis

D. McGuire, L. Elting, S. Sonis, 2007 .

Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis scoring system.

D. Tu, S. El-Sayed, E. Berthelet, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Periodontal status and bacteremia with oral viridans streptococci and coagulase negative staphylococci in allogeneic hematopoietic stem cell transplantation recipients: a prospective observational study

J. Epstein, J. Raber-Durlacher, J. Donnelly, 2013, Supportive Care in Cancer.

UvA-DARE ( Digital Academic Repository ) Factors influencing oral health in patients during cancer treatment ; with emphasis on the relationship between the oral microbiome and oral mucositis

J. Raber-Durlacher, M. Epstein, A. Laheij, 2014 .

Clinical practice guidelines for the prevention and treatment of cancer therapy–induced oral and gastrointestinal mucositis

M. Schubert, D. Keefe, C. Cooksley, 2004, Cancer.